- €6.65bn
- €7.52bn
- $2.09bn
Brief: Qiagen And Bio-Manguinhos/Fiocruz Collaborate To Enhance Malaria And Dengue Detection In Brazil’s National Screening Programs
Brief: QIAGEN And Lilly Collaborate To Support Development Of QIAstat-Dx IVD Panel
Brief: Qiagen Announces Successful Placement Of New Net Share Settled Convertible Bonds
Brief: Qiagen Launches Non-Us Offering Of Net Share Settled Convertible Bonds
Europe Research Roundup: Admiral Group, IAG, Keller Group
Brief: Qiagen Says FY Net Sales Are Expected To Be At Least $1.985 Billion CER
Brief: Qiagen NV Sees At Least $2 Billion Of Combined Annual Sales In 2028
Brief: Evotec and Qiagen enter software collaboration for insights into multi-omics data
Brief: QIAGEN And Myriad Genetics Develop Distributable Homologous Recombination Deficiency Test
Live Markets: European futures point to another down day
Brief: Qiagen Receives FDA Clearance For Qiastat-Dx Respiratory Syndromic Testing Panel
Brief: Qiagen NV Announces Launch Of Qiagen Biomedical KB-AI
Brief: Qiagen Exceeds Outlook For Q4 2023, Led By 8% CER Sales Growth In Non-Covid Products And Improved Operational Profitability
Brief: Qiagen Announces Partnership With Penn State University To Advance Microbiome Sciences
Brief: Qiagen Announces Completion Of Synthetic Share Repurchase Of Up To Approximately $300 Million
Brief: Qiagen Gets FDA Clearance Of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems
Brief: Qiagen NV To Return Approximately $300 Million To Shareholders Through A Synthetic Share Repurchase
Brief: Qiagen To Accelerate Investments Into Qiagen Digital Insights Bioinformatics Business
Brief: Qiagen Expands Business In Middle East With New Regional Headquarters And Major Projects